Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Spanish is available via eTranslation, the European Commission's machine translation service.

Translate to Spanish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Ver

español (ES) (537.02 KB - PDF)

Ver

čeština (CS) (573.8 KB - PDF)

Ver

dansk (DA) (511.6 KB - PDF)

Ver

Deutsch (DE) (515.35 KB - PDF)

Ver

eesti (ET) (539.37 KB - PDF)

Ver

ελληνικά (EL) (586.2 KB - PDF)

Ver

français (FR) (538.28 KB - PDF)

Ver

italiano (IT) (535.2 KB - PDF)

Ver

latviešu (LV) (569.81 KB - PDF)

Ver

lietuvių (LT) (534.12 KB - PDF)

Ver

magyar (HU) (548.34 KB - PDF)

Ver

Malti (MT) (576.33 KB - PDF)

Ver

Nederlands (NL) (513.44 KB - PDF)

Ver

polski (PL) (552.75 KB - PDF)

Ver

português (PT) (535.52 KB - PDF)

Ver

română (RO) (533.59 KB - PDF)

Ver

slovenčina (SK) (570.05 KB - PDF)

Ver

slovenščina (SL) (564.24 KB - PDF)

Ver

suomi (FI) (533.75 KB - PDF)

Ver

svenska (SV) (535.74 KB - PDF)

Ver

Product information

български (BG) (1.46 MB - PDF)

Ver

español (ES) (876.92 KB - PDF)

Ver

čeština (CS) (1.18 MB - PDF)

Ver

dansk (DA) (873.6 KB - PDF)

Ver

Deutsch (DE) (889.37 KB - PDF)

Ver

eesti (ET) (830.81 KB - PDF)

Ver

ελληνικά (EL) (1.51 MB - PDF)

Ver

français (FR) (864.23 KB - PDF)

Ver

hrvatski (HR) (875.28 KB - PDF)

Ver

italiano (IT) (859.62 KB - PDF)

Ver

latviešu (LV) (1.25 MB - PDF)

Ver

lietuvių (LT) (810.52 KB - PDF)

Ver

magyar (HU) (1.25 MB - PDF)

Ver

Malti (MT) (1.26 MB - PDF)

Ver

Nederlands (NL) (855.45 KB - PDF)

Ver

polski (PL) (1.23 MB - PDF)

Ver

português (PT) (838.3 KB - PDF)

Ver

română (RO) (1 MB - PDF)

Ver

slovenčina (SK) (1.18 MB - PDF)

Ver

slovenščina (SL) (1.13 MB - PDF)

Ver

suomi (FI) (858.03 KB - PDF)

Ver

svenska (SV) (851.7 KB - PDF)

Ver

Íslenska (IS) (879.42 KB - PDF)

Ver

norsk (NO) (836.37 KB - PDF)

Ver
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Ver

español (ES) (458.29 KB - PDF)

Ver

čeština (CS) (487.32 KB - PDF)

Ver

dansk (DA) (460.34 KB - PDF)

Ver

Deutsch (DE) (460.75 KB - PDF)

Ver

eesti (ET) (460.29 KB - PDF)

Ver

ελληνικά (EL) (495.78 KB - PDF)

Ver

français (FR) (460.31 KB - PDF)

Ver

hrvatski (HR) (471.53 KB - PDF)

Ver

italiano (IT) (460.57 KB - PDF)

Ver

latviešu (LV) (491.15 KB - PDF)

Ver

lietuvių (LT) (475.45 KB - PDF)

Ver

magyar (HU) (485.61 KB - PDF)

Ver

Malti (MT) (488.27 KB - PDF)

Ver

Nederlands (NL) (458.26 KB - PDF)

Ver

polski (PL) (485.72 KB - PDF)

Ver

português (PT) (460.24 KB - PDF)

Ver

română (RO) (474.03 KB - PDF)

Ver

slovenčina (SK) (487.71 KB - PDF)

Ver

slovenščina (SL) (477.71 KB - PDF)

Ver

suomi (FI) (458.28 KB - PDF)

Ver

svenska (SV) (460.23 KB - PDF)

Ver

Íslenska (IS) (457.47 KB - PDF)

Ver

norsk (NO) (461.18 KB - PDF)

Ver

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page